People With Allowed Injury Claims Against Opioid Maker Endo Are Being Paid $390, or $1,950 if They Granted an Extra Release
People who say they were hurt by opioids made by Endo filed their injury claims in the drugmaker’s bankruptcy years ago, then waited through claim reviews, status letters and a long check on their medical bills. For those whose claims were allowed, the money is now moving.
The Endo Opioid Personal Injury Trust says on its official website that it is paying $390 per allowed claim, or $1,950 to claimants who timely granted an extra legal release known as the non-GUC release. Payments to claims that cleared medical lien review began in April 2026 and are continuing, according to the trust’s Oct. 1 update, signed by trustee and claims administrator Ed Gentle. Both amounts are gross, before administrative fees, medical liens and attorney fees come out.
Where the $390 and $1,950 Figures Come From
The trust calls $390 its pro rata estimate, the share each allowed claim gets when the trust’s money is divided by the number of allowed claims. Claimants who granted the non-GUC release on time get a multiplier of four times that amount, an added $1,560, for a combined $1,950.
The trust’s distribution procedures explain the trade. Claimants who granted the release gave up claims against a set of parties beyond Endo itself, known in the plan as the non-GUC released parties, and in return earned the right to the additional payment. The procedures say the releases are irrevocable and had to be granted by the voting deadline in the bankruptcy. They also say the trust compensates only general pain and suffering, with no value given to economic damages, punitive damages or attorney fees.
The procedures illustrate the math with a sample figure. With a $250 pro rata payment, a claimant without the release would get $250, while one who granted it would get $250 plus a $1,000 additional award, for $1,250. Applied to the current $390 estimate, the same formula produces the $1,950 figure.
The figures are estimates. Open Class Actions, which tracks settlements, noted in a Nov. 3 report that the per-claim amount depends on how many claims are allowed, and that the trust has not published that count.
The Lien Check That Comes Before Any Payment
No allowed claim is paid until it clears lien resolution. According to the trust’s lien resolution page, health insurers including Medicare, Medicaid and private plans such as UnitedHealthcare and Blue Cross can seek reimbursement out of an award for treatment tied to the opioid claim.
A Lien Resolution Administrator gathers those claims, checks them and works to bring them down. The page says the goal is to minimize the lien amounts, and that negotiated programs include automatic reductions and maximum amounts for many of them. The court, the plan and the trustee all require the review, and the trust says most claimants should finish it within 12 months of providing their information, with some faster and some slower.
Claimants do not have to do anything beyond the health insurance details they gave on their claim form. Those with a lawyer go through the lawyer, since the administrator cannot communicate directly with represented claimants.
Emails to Claimants Without Lawyers Started Sept. 28
For people who filed on their own, the trust administrator emails the address on file to confirm a mailing address once a claim clears the lien process. The trust says those clearance emails began going out on Sept. 28, 2026, on a rolling basis, and that no email is sent until the claim has cleared. Represented claimants get payment coordination from their attorneys.
The trust does not list a phone number or email address. It takes questions through a contact form on its website.
Who Is in Line, and Who Missed the Window
Only people with allowed claims are being paid, and the deadlines to get into the trust have long passed. The trust’s dates and deadlines page shows the bankruptcy plan was confirmed on March 22, 2024, and took effect April 23, 2024. Personal injury claim forms were due May 23, 2024, and each claimant also needed a proof of claim filed in the bankruptcy by the general bar date of July 7, 2023.
To be allowed, a claim had to show use of a qualifying Endo opioid before Jan. 1, 2019, backed by records such as pharmacy or prescription records in the claimant’s name, along with a signed HIPAA release, according to the distribution procedures. Claims brought on behalf of people who died required an heirship declaration.
Filing for this trust is closed. The trust says future personal injury claims are handled separately, by the Endo Future PI Trust, which runs its own website.
Babies Born Dependent Are on a Separate Track
A second trust covers neonatal abstinence syndrome, the withdrawal some babies go through after exposure to opioids in the womb. The Endo NAS Personal Injury Trust lists a gross estimate of $385.65 per allowed claim, or $1,928.25 with the four-times multiplier for those who granted the release.
That trust is still reviewing claims and working through deficiencies, and its lien review is ongoing. Its page had estimated payments would begin in the first quarter of 2026, but the trust’s October update shows the process is still underway, and no confirmed start date for those payments has been posted. NAS claims had a later filing deadline of April 23, 2025.
For more on settlement payouts that are moving, or stalled, the site has covered 23andMe’s data breach payments and the appeal freezing Capital One’s 360 Savings settlement.
This article was produced with AI assistance and edited for accuracy against the sources linked above.
Image: Zalasem1 – CC BY 4.0/Wikimedia Commons
